Agenda of the 4th Mini Measles Rubella Symposium
Vaccination is among the greatest public health achievements of the 20th century, banishing feared diseases from the lives of those fortunate enough to be immunized. But 1.5 million people continue to die each year from vaccine-preventable diseases.
The Global Vaccine Action Plan
The Global Vaccine Action Plan (GVAP) is a framework to end that inequity and extend the benefits of vaccination to everyone, regardless of where they are born.
September 29, 2012 | The Lancet
Sabin Executive Vice President, Dr. Ciro de Quadros recently co-authored the following correspondence, which appeared in the September 29 edition of the Lancet.
Reducing the global burden of congenital rubella syndrome
Rubella, also known as German Measles, is an often mild disease whose symptoms can range from a fever and rash to signs too mild to detect. When contracted by a pregnant woman in her first 20 weeks, however, rubella can lead to Congenital Rubella Syndrome (CRS) in the fetus, and the effects can be devastating. The disease can cause severe growth and mental retardation, deafness and other developmental problems when the fetus becomes infected.